English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Vifor Pharma
Press release submission
| Dec 10, 2021
First patient enrolled in phase-IIa study of vamifeport in patients with sickle cell disease
Nicholas Gueguen
| Aug 13, 2017
Vifor Pharma begins new tests of Ferinject in patients with heart failure, iron deficiency
Robert Hadley
| Apr 28, 2017
Vifor Pharma offers grants aimed at combating iron deficiency
Gene Johnson
| Mar 1, 2017
Vifor buys rights to sell renal treatment in most of Asia
Carol Ostrow
| Feb 16, 2017
Swiss company holds iron deficiency to the fire
Keri Carbaugh
| Jan 6, 2017
Kidney Health Alliance expands to include CCX140
Amanda Rupp
| Jun 11, 2016
Vifor Pharma grants Pfizer commercialization rights
Amanda Rupp
| May 25, 2016
Vifor Pharma buys rights to rare renal disease treatment
Trending
+
Pharmaceuticals
Patient Daily
| Sep 23, 2025
Wall Street Journal editorial board alleges hospitals misuse 340B program
+
Pharmaceuticals
Patient Daily
| Sep 22, 2025
Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program
+
Pharmaceuticals
Patient Daily
| Sep 22, 2025
Staff Attorney of Legal Aid Society on 340B: 'Hospitals are exploiting the 340B program'
+
Marketing
Patient Daily
| Sep 17, 2025
Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'
